Neuroprotective effects of thymoquinone against ketamine -and MK-801-induced neurotoxicity in SH-SY5Y cells: From the perspective of glutamatergic dysfunction in schizophrenia

---

Atıf İçin Kopyala

ÜNAL G., Erdogan B.

CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, cilt.10, sa.2, ss.178-182, 2020 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 10 Sayı: 2
• Basım Tarihi: 2020
• Doi Numarası: 10.33808/clinexphealthsci.734422
• Dergi Adı: CLINICAL AND EXPERIMENTAL HEALTH SCIENCES
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.178-182
• Erciyes Üniversitesi Adresli: Evet

Özet

Objective: Schizophrenia is a chronic disorder with approximately 1% prevalence and related to disrupted neurodevelopment process. It has been known that N-methyl D-Aspartate (NMDA) receptor antagonists such as ketamine and MK-801 mimic schizophrenia-like behaviors in rodents and cellular changes in cell culture. There are certain preliminary reports showing the beneficial effects of Nigella sativa L. extracts or its main active ingredient, thymoquinone, on psychiatric disorders. In our study, we aimed to investigate the neuroprotective effects of thymoquinone against ketamine - and MK-801 - induced neurotoxicites, which may be relevant to schizophrenia.